Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Bioavailability of CuminUP30 in Healthy Adults
NCT05334043Phase 1Unknown
- Sponsor
- The Affiliated Hospital of Qingdao University
- Start
- Mar 2022
- Primary completion
- Apr 2022
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial (2 arms), sponsored by The Affiliated Hospital of Qingdao University. Primary endpoint: Peak Plasma Concentration. Status: unknown.
Beyond the preview
Go deeper on NCT05334043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05334043.